{"title":"具有抗癌治疗潜力的1,2,3-三唑化合物的现状：第二部分","authors":"Zhi Xu, Junna Liu","doi":"10.1002/ardp.202500031","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Chemotherapy has been identified as a validated and critically important strategy for the treatment of cancer, but multidrug resistance and serious side effects remain grand challenges for effective cancer therapy. This highlights the urgent need for the development of alternative chemical entities that can modulate more than one biological target with high specificity and multitargeted mechanism of action in the disease progression pathway. 1,2,3-Triazole hybrids have the potential to act on dual/multiple targets in cancer cells simultaneously and possess potent broad-spectrum activity against various cancers, including drug-resistant forms. Thus, 1,2,3-triazole hybrids are valuable scaffolds in the treatment and eradication of cancer. This review provides a comprehensive overview of the evolving landscape of 1,2,3-triazole hybrids with their in vitro and in vivo anticancer potential, and the structure–activity relationships as well as mechanisms of action are also discussed, covering articles published from 2021 onward.</p></div>","PeriodicalId":128,"journal":{"name":"Archiv der Pharmazie","volume":"358 4","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Current Landscape of 1,2,3-triazole Hybrids With Anticancer Therapeutic Potential: Part II\",\"authors\":\"Zhi Xu, Junna Liu\",\"doi\":\"10.1002/ardp.202500031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>Chemotherapy has been identified as a validated and critically important strategy for the treatment of cancer, but multidrug resistance and serious side effects remain grand challenges for effective cancer therapy. This highlights the urgent need for the development of alternative chemical entities that can modulate more than one biological target with high specificity and multitargeted mechanism of action in the disease progression pathway. 1,2,3-Triazole hybrids have the potential to act on dual/multiple targets in cancer cells simultaneously and possess potent broad-spectrum activity against various cancers, including drug-resistant forms. Thus, 1,2,3-triazole hybrids are valuable scaffolds in the treatment and eradication of cancer. This review provides a comprehensive overview of the evolving landscape of 1,2,3-triazole hybrids with their in vitro and in vivo anticancer potential, and the structure–activity relationships as well as mechanisms of action are also discussed, covering articles published from 2021 onward.</p></div>\",\"PeriodicalId\":128,\"journal\":{\"name\":\"Archiv der Pharmazie\",\"volume\":\"358 4\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archiv der Pharmazie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ardp.202500031\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archiv der Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ardp.202500031","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
The Current Landscape of 1,2,3-triazole Hybrids With Anticancer Therapeutic Potential: Part II
Chemotherapy has been identified as a validated and critically important strategy for the treatment of cancer, but multidrug resistance and serious side effects remain grand challenges for effective cancer therapy. This highlights the urgent need for the development of alternative chemical entities that can modulate more than one biological target with high specificity and multitargeted mechanism of action in the disease progression pathway. 1,2,3-Triazole hybrids have the potential to act on dual/multiple targets in cancer cells simultaneously and possess potent broad-spectrum activity against various cancers, including drug-resistant forms. Thus, 1,2,3-triazole hybrids are valuable scaffolds in the treatment and eradication of cancer. This review provides a comprehensive overview of the evolving landscape of 1,2,3-triazole hybrids with their in vitro and in vivo anticancer potential, and the structure–activity relationships as well as mechanisms of action are also discussed, covering articles published from 2021 onward.
期刊介绍：
Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
